| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.964 | 0.001 | 0.964 | Androgen antagonist | 0.86 0.002 DBMET02809 0.881 0.002 DBMET02811 0.911 0.002 DBMET02812 0.945 0.002 DBMET02813 | ||
| 0.94 | 0.005 | 0.967 | Antiinflammatory | 0.892 0.005 DBMET02809 0.949 0.004 DBMET02811 0.933 0.005 DBMET02812 0.967 0.004 DBMET02813 | DBMET02813 | |
| 0.851 | 0.001 | 0.919 | Androgen agonist | 0.576 0.002 DBMET02809 0.919 0.001 DBMET02811 0.836 0.001 DBMET02812 0.824 0.001 DBMET02813 | DBMET02811 | |
| 0.85 | 0.001 | 0.85 | Progesterone antagonist | 0.801 0.001 DBMET02809 0.728 0.001 DBMET02811 0.742 0.001 DBMET02812 0.806 0.001 DBMET02813 | ||
| 0.85 | 0.003 | 0.92 | Hypoxia-inducible factor 1 alpha inhibitor | 0.742 0.004 DBMET02809 0.92 0.002 DBMET02811 0.846 0.003 DBMET02812 0.879 0.002 DBMET02813 | DBMET02811 | |
| 0.786 | 0.003 | 0.844 | Antipruritic | 0.402 0.006 DBMET02809 0.711 0.003 DBMET02811 0.705 0.003 DBMET02812 0.844 0.002 DBMET02813 | DBMET02813 | |
| 0.778 | 0.001 | 0.783 | Lipocortins synthesis antagonist | 0.783 0.001 DBMET02809 0.719 0.001 DBMET02811 0.734 0.001 DBMET02812 0.779 0.001 DBMET02813 | DBMET02809 | |
| 0.779 | 0.014 | 0.884 | Transcription factor NF kappa B inhibitor | 0.778 0.014 DBMET02809 0.882 0.007 DBMET02811 0.884 0.007 DBMET02812 0.793 0.013 DBMET02813 | DBMET02812 | |
| 0.757 | 0.001 | 0.757 | Progesterone agonist | 0.663 0.001 DBMET02809 0.53 0.001 DBMET02811 0.566 0.001 DBMET02812 0.677 0.001 DBMET02813 | ||
| 0.757 | 0.022 | 0.838 | Apoptosis agonist | 0.719 0.028 DBMET02809 0.838 0.012 DBMET02811 0.777 0.019 DBMET02812 0.756 0.022 DBMET02813 | DBMET02811 | |
| 0.727 | 0.002 | 0.746 | Aromatase inhibitor | 0.472 0.004 DBMET02809 0.746 0.002 DBMET02811 0.609 0.003 DBMET02812 0.737 0.002 DBMET02813 | DBMET02811 | |
| 0.701 | 0.005 | 0.735 | Immunosuppressant | 0.613 0.012 DBMET02809 0.707 0.005 DBMET02811 0.735 0.004 DBMET02812 0.73 0.004 DBMET02813 | DBMET02812 | |
| 0.678 | 0.001 | 0.678 | 5-Alpha-reductase inhibitor | 0.403 0.002 DBMET02809 0.483 0.001 DBMET02811 0.479 0.001 DBMET02812 0.64 0.001 DBMET02813 | ||
| 0.63 | 0.002 | 0.63 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.27 0.003 DBMET02809 0.472 0.002 DBMET02811 0.405 0.003 DBMET02812 0.546 0.002 DBMET02813 | ||
| 0.603 | 0.003 | 0.603 | Estrogen receptor alpha antagonist | 0.4 0.004 DBMET02809 0.524 0.003 DBMET02811 0.599 0.003 DBMET02812 0.333 0.004 DBMET02813 | ||
| 0.592 | 0.02 | 0.592 | Cholesterol antagonist | 0.561 0.024 DBMET02809 0.513 0.031 DBMET02811 0.503 0.032 DBMET02812 0.332 0.073 DBMET02813 | ||
| 0.551 | 0.004 | 0.587 | Interferon gamma antagonist | 0.567 0.003 DBMET02809 0.587 0.003 DBMET02811 0.558 0.004 DBMET02812 0.563 0.003 DBMET02813 | DBMET02811 | |
| 0.584 | 0.038 | 0.683 | Caspase 9 stimulant | 0.683 0.026 DBMET02809 0.513 0.055 DBMET02811 0.645 0.03 DBMET02812 0.423 0.098 DBMET02813 | DBMET02809 | |
| 0.544 | 0.002 | 0.544 | Glucocorticoid antagonist | 0.426 0.002 DBMET02809 0.374 0.002 DBMET02811 0.382 0.002 DBMET02812 0.525 0.002 DBMET02813 | ||
| 0.521 | 0.001 | 0.521 | 5-Alpha-reductase 1 inhibitor | 0.324 0.002 DBMET02809 0.35 0.002 DBMET02811 0.369 0.002 DBMET02812 0.502 0.001 DBMET02813 | ||
| 0.49 | 0.003 | 0.49 | Mineralocorticoid receptor antagonist | 0.316 0.004 DBMET02809 0.242 0.004 DBMET02811 0.294 0.004 DBMET02812 0.429 0.003 DBMET02813 | ||
| 0.484 | 0.009 | 0.484 | Anesthetic general | 0.456 0.011 DBMET02809 0.434 0.013 DBMET02811 0.437 0.012 DBMET02812 0.241 0.054 DBMET02813 | ||
| 0.477 | 0.01 | 0.524 | P-glycoprotein inhibitor | 0.524 0.007 DBMET02809 0.389 0.017 DBMET02811 0.469 0.01 DBMET02812 0.422 0.014 DBMET02813 | DBMET02809 | |
| 0.461 | 0.001 | 0.638 | Glucocorticoid agonist | 0.258 0.002 DBMET02809 0.412 0.001 DBMET02811 0.341 0.002 DBMET02812 0.638 0.001 DBMET02813 | DBMET02813 | |
| 0.459 | 0.006 | 0.469 | Sodium/bile acid cotransporter inhibitor | 0.459 0.006 DBMET02809 0.439 0.009 DBMET02811 0.469 0.005 DBMET02812 0.436 0.009 DBMET02813 | DBMET02812 | |
| 0.453 | 0.004 | 0.453 | Estrogen agonist | 0.408 0.004 DBMET02809 0.42 0.004 DBMET02811 0.436 0.004 DBMET02812 0.359 0.004 DBMET02813 | ||
| 0.451 | 0.004 | 0.451 | Estrogen antagonist | 0.358 0.005 DBMET02809 0.336 0.005 DBMET02811 0.421 0.004 DBMET02812 0.409 0.004 DBMET02813 | ||
| 0.445 | 0 | 0.46 | Arachidonic acid antagonist | 0.372 0.001 DBMET02809 0.46 0 DBMET02811 0.43 0 DBMET02812 0.454 0 DBMET02813 | DBMET02811 | |
| 0.442 | 0.021 | 0.544 | Nitric oxide antagonist | 0.393 0.026 DBMET02809 0.51 0.015 DBMET02811 0.531 0.014 DBMET02812 0.544 0.013 DBMET02813 | DBMET02813 | |
| 0.406 | 0.001 | 0.443 | Anabolic | 0.305 0.001 DBMET02809 0.44 0.001 DBMET02811 0.443 0.001 DBMET02812 0.4 0.001 DBMET02813 | DBMET02812 | |
| 0.407 | 0.007 | 0.443 | Interleukin 6 antagonist | 0.396 0.008 DBMET02809 0.443 0.005 DBMET02811 0.336 0.011 DBMET02812 0.429 0.006 DBMET02813 | DBMET02811 | |
| 0.4 | 0.002 | 0.4 | Ornithine decarboxylase inhibitor | 0.192 0.005 DBMET02809 0.288 0.003 DBMET02811 0.284 0.003 DBMET02812 0.24 0.004 DBMET02813 | ||
| 0.378 | 0.001 | 0.378 | 5-Alpha-reductase 2 inhibitor | 0.286 0.002 DBMET02809 0.241 0.002 DBMET02811 0.267 0.002 DBMET02812 0.356 0.002 DBMET02813 | ||
| 0.364 | 0.002 | 0.364 | Aldosterone antagonist | 0.285 0.003 DBMET02809 0.207 0.004 DBMET02811 0.198 0.004 DBMET02812 0.32 0.003 DBMET02813 | ||
| 0.348 | 0.009 | 0.366 | Neurotrophic factor enhancer | 0.355 0.009 DBMET02809 0.325 0.013 DBMET02811 0.325 0.013 DBMET02812 0.366 0.008 DBMET02813 | DBMET02813 | |
| 0.3 | 0.004 | 0.3 | Estrogen receptor beta agonist | 0.202 0.005 DBMET02809 0.213 0.004 DBMET02811 0.273 0.004 DBMET02812 0.197 0.005 DBMET02813 | ||
| 0.342 | 0.049 | 0.351 | Interleukin 2 agonist | 0.326 0.057 DBMET02809 0.336 0.052 DBMET02811 0.351 0.045 DBMET02812 0.238 0.133 DBMET02813 | DBMET02812 | |
| 0.312 | 0.02 | 0.313 | Diuretic | 0.313 0.02 DBMET02809 0.142 0.084 DBMET02811 0.143 0.083 DBMET02812 0.281 0.026 DBMET02813 | DBMET02809 | |
| 0.283 | 0.001 | 0.283 | Progesterone receptor A antagonist | 0.125 0.001 DBMET02809 0.104 0.001 DBMET02811 0.107 0.001 DBMET02812 0.11 0.001 DBMET02813 | ||
| 0.283 | 0.005 | 0.283 | Estrogen receptor beta antagonist | 0.227 0.008 DBMET02809 0.188 0.01 DBMET02811 0.257 0.006 DBMET02812 0.195 0.01 DBMET02813 | ||
| 0.294 | 0.019 | 0.319 | NOS3 expression enhancer | 0.233 0.03 DBMET02809 0.232 0.031 DBMET02811 0.319 0.015 DBMET02812 0.244 0.028 DBMET02813 | DBMET02812 | |
| 0.273 | 0.002 | 0.294 | RNA-directed RNA polymerase stimulant | 0.294 0.002 DBMET02809 0.184 0.003 DBMET02811 0.239 0.003 DBMET02812 0.14 0.004 DBMET02813 | DBMET02809 | |
| 0.283 | 0.013 | 0.336 | Cholesterol synthesis inhibitor | 0.308 0.011 DBMET02809 0.336 0.008 DBMET02811 0.298 0.012 DBMET02812 0.197 0.027 DBMET02813 | DBMET02811 | |
| 0.297 | 0.029 | 0.313 | Non-steroidal antiinflammatory agent | 0.144 0.123 DBMET02809 0.237 0.048 DBMET02811 0.208 0.065 DBMET02812 0.313 0.025 DBMET02813 | DBMET02813 | |
| 0.325 | 0.07 | 0.358 | Apoptosis antagonist | 0.329 0.067 DBMET02809 0.358 0.052 DBMET02811 0.308 0.08 DBMET02812 0.294 0.089 DBMET02813 | DBMET02811 | |
| 0.252 | 0.001 | 0.379 | Lipocortins synthesis agonist | 0.187 0.001 DBMET02809 0.229 0.001 DBMET02811 0.214 0.001 DBMET02812 0.379 0 DBMET02813 | DBMET02813 | |
| 0.338 | 0.088 | 0.685 | Toll-Like receptor 7 agonist | 0.379 0.068 DBMET02811 0.234 0.163 DBMET02812 0.685 0.01 DBMET02813 | DBMET02813 | |
| 0.281 | 0.035 | 0.332 | Hepatoprotectant | 0.289 0.033 DBMET02809 0.332 0.022 DBMET02811 0.315 0.025 DBMET02812 0.252 0.043 DBMET02813 | DBMET02811 | |
| 0.329 | 0.093 | 0.678 | Toll-Like receptor agonist | 0.371 0.072 DBMET02811 0.227 0.172 DBMET02812 0.678 0.01 DBMET02813 | DBMET02813 | |
| 0.239 | 0.015 | 0.328 | Antineoplastic antibiotic | 0.227 0.017 DBMET02809 0.328 0.008 DBMET02811 0.27 0.012 DBMET02812 0.224 0.017 DBMET02813 | DBMET02811 | |
| 0.286 | 0.063 | 0.286 | DNA damaging | 0.222 0.099 DBMET02809 0.176 0.138 DBMET02811 0.216 0.103 DBMET02812 0.251 0.079 DBMET02813 | ||
| 0.298 | 0.079 | 0.518 | Caspase 3 stimulant | 0.282 0.088 DBMET02809 0.518 0.018 DBMET02811 0.435 0.034 DBMET02812 0.233 0.128 DBMET02813 | DBMET02811 | |
| 0.222 | 0.016 | 0.256 | Farnesoid X receptor antagonist | 0.218 0.017 DBMET02809 0.178 0.03 DBMET02811 0.226 0.015 DBMET02812 0.256 0.01 DBMET02813 | DBMET02813 | |
| 0.275 | 0.072 | 0.378 | Antioxidant | 0.343 0.048 DBMET02809 0.378 0.039 DBMET02811 0.349 0.047 DBMET02812 0.282 0.069 DBMET02813 | DBMET02811 | |
| 0.221 | 0.034 | 0.327 | Melanin inhibitor | 0.327 0.019 DBMET02809 0.316 0.02 DBMET02811 0.21 0.037 DBMET02812 0.157 0.073 DBMET02813 | DBMET02809 | |
| 0.187 | 0.001 | 0.282 | Corticosteroid-like | 0.129 0.001 DBMET02809 0.16 0.001 DBMET02811 0.14 0.001 DBMET02812 0.282 0.001 DBMET02813 | DBMET02813 | |
| 0.251 | 0.066 | 0.347 | DNA synthesis inhibitor | 0.261 0.06 DBMET02809 0.336 0.033 DBMET02811 0.34 0.032 DBMET02812 0.347 0.031 DBMET02813 | DBMET02813 | |
| 0.219 | 0.035 | 0.242 | Protein kinase stimulant | 0.24 0.029 DBMET02809 0.199 0.042 DBMET02811 0.242 0.028 DBMET02812 0.158 0.063 DBMET02813 | DBMET02812 | |
| 0.308 | 0.129 | 0.48 | Antibacterial | 0.351 0.101 DBMET02809 0.48 0.046 DBMET02811 0.458 0.054 DBMET02812 0.215 0.212 DBMET02813 | DBMET02811 | |
| 0.206 | 0.039 | 0.329 | Lipid peroxidase inhibitor | 0.204 0.04 DBMET02809 0.252 0.027 DBMET02811 0.245 0.028 DBMET02812 0.329 0.015 DBMET02813 | DBMET02813 | |
| 0.178 | 0.013 | 0.181 | Prolactin inhibitor | 0.133 0.03 DBMET02809 0.144 0.025 DBMET02811 0.144 0.025 DBMET02812 0.181 0.013 DBMET02813 | DBMET02813 | |
| 0.177 | 0.02 | 0.177 | Pregnane X receptor agonist | 0.137 0.08 DBMET02809 0.158 0.039 DBMET02811 0.155 0.045 DBMET02812 0.125 0.113 DBMET02813 | ||
| 0.181 | 0.025 | 0.238 | Microtubule formation inhibitor | 0.198 0.02 DBMET02809 0.202 0.019 DBMET02811 0.238 0.012 DBMET02812 0.173 0.028 DBMET02813 | DBMET02812 | |
| 0.168 | 0.013 | 0.173 | Toll-Like receptor 4 antagonist | 0.15 0.021 DBMET02809 0.155 0.019 DBMET02811 0.144 0.024 DBMET02812 0.173 0.011 DBMET02813 | DBMET02813 | |
| 0.15 | 0.007 | 0.189 | Glycine receptor agonist | 0.121 0.012 DBMET02809 0.189 0.004 DBMET02811 0.15 0.007 DBMET02812 0.108 0.017 DBMET02813 | DBMET02811 | |
| 0.144 | 0.004 | 0.144 | Estrone sulfatase inhibitor | 0.13 0.004 DBMET02809 0.094 0.005 DBMET02811 0.1 0.005 DBMET02812 0.122 0.004 DBMET02813 | ||
| 0.14 | 0.005 | 0.169 | Estrogen receptor alpha agonist | 0.169 0.005 DBMET02809 0.11 0.007 DBMET02811 0.156 0.005 DBMET02812 0.09 0.01 DBMET02813 | DBMET02809 | |
| 0.154 | 0.026 | 0.236 | Antineoplastic alkaloid | 0.236 0.006 DBMET02809 0.154 0.027 DBMET02811 0.154 0.027 DBMET02812 0.223 0.008 DBMET02813 | DBMET02809 | |
| 0.137 | 0.011 | 0.138 | Glycine receptor antagonist | 0.105 0.028 DBMET02809 0.138 0.01 DBMET02811 0.119 0.019 DBMET02812 0.09 0.042 DBMET02813 | DBMET02811 | |
| 0.248 | 0.124 | 0.339 | Angiogenesis inhibitor | 0.339 0.076 DBMET02811 0.268 0.111 DBMET02812 0.233 0.136 DBMET02813 | DBMET02811 | |
| 0.132 | 0.007 | 0.227 | Estradiol 17 beta-dehydrogenase inhibitor | 0.227 0.004 DBMET02809 0.071 0.015 DBMET02811 0.155 0.005 DBMET02812 0.07 0.016 DBMET02813 | DBMET02809 | |
| 0.133 | 0.01 | 0.139 | Na+ K+ transporting ATPase inhibitor | 0.128 0.012 DBMET02809 0.139 0.008 DBMET02811 0.137 0.009 DBMET02812 0.113 0.021 DBMET02813 | DBMET02811 | |
| 0.227 | 0.109 | 0.227 | Gastrin inhibitor | 0.197 0.154 DBMET02809 | ||
| 0.194 | 0.077 | 0.236 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.236 0.049 DBMET02809 0.218 0.059 DBMET02811 0.183 0.089 DBMET02812 | DBMET02809 | |
| 0.157 | 0.045 | 0.171 | DNA polymerase I inhibitor | 0.171 0.039 DBMET02809 0.171 0.039 DBMET02811 0.142 0.054 DBMET02812 0.105 0.081 DBMET02813 | DBMET02811 | |
| 0.116 | 0.004 | 0.116 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.05 0.008 DBMET02809 0.094 0.004 DBMET02811 0.06 0.007 DBMET02812 0.035 0.014 DBMET02813 | ||
| 0.151 | 0.041 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.176 0.009 DBMET02809 0.16 0.024 DBMET02811 0.16 0.024 DBMET02812 0.148 0.048 DBMET02813 | DBMET02809 | |
| 0.202 | 0.094 | 0.227 | Angiogenesis stimulant | 0.177 0.107 DBMET02809 0.227 0.081 DBMET02811 0.216 0.087 DBMET02812 | DBMET02811 | |
| 0.21 | 0.112 | 0.21 | Interleukin agonist | 0.179 0.141 DBMET02811 0.182 0.137 DBMET02812 | ||
| 0.136 | 0.044 | 0.157 | Interleukin 8 antagonist | 0.157 0.03 DBMET02809 0.109 0.078 DBMET02811 0.145 0.037 DBMET02813 | DBMET02809 | |
| 0.092 | 0.004 | 0.107 | Pregnane X receptor antagonist | 0.107 0.003 DBMET02809 0.066 0.019 DBMET02811 0.067 0.018 DBMET02812 0.058 0.035 DBMET02813 | DBMET02809 | |
| 0.191 | 0.113 | 0.191 | RNA-directed DNA polymerase inhibitor | 0.18 0.132 DBMET02809 0.184 0.125 DBMET02811 0.184 0.125 DBMET02812 | ||
| 0.081 | 0.004 | 0.081 | Glucose-6-phosphate dehydrogenase inhibitor | 0.079 0.004 DBMET02809 0.069 0.005 DBMET02811 0.065 0.006 DBMET02812 0.065 0.005 DBMET02813 | ||
| 0.108 | 0.031 | 0.114 | Inducible nitric-oxide synthase inhibitor | 0.114 0.027 DBMET02813 | DBMET02813 | |
| 0.129 | 0.056 | 0.171 | Monophenol monooxygenase inhibitor | 0.171 0.04 DBMET02809 0.12 0.061 DBMET02811 0.097 0.079 DBMET02812 0.16 0.043 DBMET02813 | DBMET02809 | |
| 0.107 | 0.035 | 0.11 | Bile acid receptor antagonist | 0.1 0.05 DBMET02809 0.097 0.056 DBMET02811 0.11 0.032 DBMET02812 0.091 0.071 DBMET02813 | DBMET02812 | |
| 0.076 | 0.005 | 0.217 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.217 0.003 DBMET02809 0.035 0.019 DBMET02811 0.047 0.012 DBMET02812 0.046 0.013 DBMET02813 | DBMET02809 | |
| 0.081 | 0.016 | 0.081 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.07 0.022 DBMET02809 0.064 0.026 DBMET02811 0.065 0.025 DBMET02812 0.054 0.036 DBMET02813 | ||
| 0.078 | 0.016 | 0.124 | Heme oxygenase stimulant | 0.081 0.014 DBMET02809 0.074 0.02 DBMET02811 0.074 0.02 DBMET02812 0.124 0.004 DBMET02813 | DBMET02813 | |
| 0.074 | 0.014 | 0.074 | Potassium channel Kv1.3 blocker | 0.06 0.021 DBMET02809 0.056 0.023 DBMET02811 0.056 0.024 DBMET02812 0.063 0.019 DBMET02813 | ||
| 0.121 | 0.067 | 0.185 | Alkylator | 0.185 0.031 DBMET02809 0.102 0.086 DBMET02811 0.123 0.065 DBMET02812 0.133 0.057 DBMET02813 | DBMET02809 | |
| 0.054 | 0.001 | 0.073 | Transcortin receptor antagonist | 0.041 0.001 DBMET02809 0.073 0.001 DBMET02811 0.073 0.001 DBMET02812 0.05 0.001 DBMET02813 | DBMET02812 | |
| 0.174 | 0.12 | 0.341 | Aldehyde oxidase inhibitor | 0.341 0.057 DBMET02809 0.19 0.11 DBMET02811 0.29 0.069 DBMET02812 0.287 0.07 DBMET02813 | DBMET02809 | |
| 0.051 | 0.003 | 0.051 | Progesterone receptor B antagonist | 0.033 0.004 DBMET02809 0.033 0.004 DBMET02811 0.038 0.004 DBMET02812 0.037 0.004 DBMET02813 | ||
| 0.107 | 0.061 | 0.174 | Expectorant | 0.168 0.029 DBMET02811 0.174 0.027 DBMET02812 0.11 0.059 DBMET02813 | DBMET02812 | |
| 0.059 | 0.016 | 0.069 | Microtubule stabilization | 0.057 0.018 DBMET02809 0.061 0.013 DBMET02811 0.069 0.007 DBMET02812 0.057 0.018 DBMET02813 | DBMET02812 | |
| 0.091 | 0.05 | 0.136 | Transcription factor NF kappa B stimulant | 0.084 0.061 DBMET02809 0.11 0.031 DBMET02811 0.109 0.032 DBMET02812 0.136 0.019 DBMET02813 | DBMET02813 | |
| 0.07 | 0.033 | 0.096 | Nitric oxide donor | 0.061 0.047 DBMET02809 0.082 0.021 DBMET02811 0.09 0.015 DBMET02812 0.096 0.01 DBMET02813 | DBMET02813 | |
| 0.1 | 0.077 | 0.144 | Mucolytic | 0.121 0.053 DBMET02811 0.144 0.036 DBMET02812 0.102 0.075 DBMET02813 | DBMET02812 | |
| 0.128 | 0.106 | 0.172 | Adenylate cyclase stimulant | 0.138 0.085 DBMET02809 0.153 0.058 DBMET02811 0.172 0.033 DBMET02812 0.126 0.111 DBMET02813 | DBMET02812 | |
| 0.053 | 0.033 | 0.061 | Glucose-6-phosphate translocase inhibitor | 0.051 0.036 DBMET02809 0.061 0.023 DBMET02811 0.056 0.029 DBMET02812 0.054 0.031 DBMET02813 | DBMET02811 | |
| 0.022 | 0.003 | 0.022 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.019 0.003 DBMET02809 0.012 0.008 DBMET02811 0.016 0.004 DBMET02812 0.017 0.004 DBMET02813 | ||
| 0.053 | 0.037 | 0.068 | Protein 50S ribosomal subunit inhibitor | 0.059 0.031 DBMET02809 0.06 0.031 DBMET02811 0.068 0.025 DBMET02812 0.047 0.043 DBMET02813 | DBMET02812 | |
| 0.141 | 0.125 | 0.218 | Interleukin antagonist | 0.14 0.126 DBMET02809 0.218 0.075 DBMET02811 0.17 0.103 DBMET02813 | DBMET02811 | |
| 0.048 | 0.032 | 0.057 | Adenosine deaminase inhibitor | 0.057 0.023 DBMET02811 0.05 0.03 DBMET02812 | DBMET02811 | |
| 0.075 | 0.06 | 0.075 | Acetylcholine nicotinic antagonist | |||
| 0.096 | 0.082 | 0.108 | Protein-tyrosine phosphatase 1B inhibitor | 0.09 0.089 DBMET02811 0.108 0.071 DBMET02812 | DBMET02812 | |
| 0.092 | 0.078 | 0.159 | Topoisomerase I inhibitor | 0.159 0.038 DBMET02809 0.092 0.077 DBMET02811 0.092 0.077 DBMET02812 | DBMET02809 | |
| 0.078 | 0.066 | 0.078 | Ca(v)3.1 blocker | |||
| 0.157 | 0.149 | 0.24 | Immunostimulant | 0.163 0.144 DBMET02809 0.215 0.112 DBMET02811 0.24 0.1 DBMET02812 | DBMET02812 | |
| 0.03 | 0.023 | 0.031 | Elastase 3A inhibitor | 0.031 0.021 DBMET02813 | DBMET02813 | |
| 0.03 | 0.023 | 0.031 | Elastase 3B inhibitor | 0.031 0.021 DBMET02813 | DBMET02813 | |
| 0.03 | 0.023 | 0.031 | Elastase 2B inhibitor | 0.031 0.021 DBMET02813 | DBMET02813 | |
| 0.071 | 0.064 | 0.08 | Keratolytic | 0.08 0.048 DBMET02809 | DBMET02809 | |
| 0.084 | 0.078 | 0.084 | ABCA1 expression enhancer | |||
| 0.016 | 0.013 | 0.018 | Vitamin D receptor agonist | 0.018 0.009 DBMET02811 0.018 0.009 DBMET02812 0.015 0.014 DBMET02813 | DBMET02812 | |
| 0.032 | 0.029 | 0.041 | Tubulin agonist | 0.038 0.017 DBMET02811 0.041 0.014 DBMET02812 0.032 0.03 DBMET02813 | DBMET02812 | |
| 0.078 | 0.075 | 0.089 | Estrogen-related receptor beta agonist | 0.086 0.049 DBMET02809 0.08 0.067 DBMET02811 0.089 0.042 DBMET02812 0.08 0.066 DBMET02813 | DBMET02812 | |
| 0.075 | 0.074 | 0.084 | GABA A receptor agonist | 0.084 0.057 DBMET02809 | DBMET02809 | |
| 0.204 | 0.207 | 0.248 | Calcium channel activator | 0.248 0.149 DBMET02812 0.206 0.204 DBMET02813 | DBMET02812 | |
| 0.183 | 0.19 | 0.186 | 5 Hydroxytryptamine uptake stimulant | 0.186 0.183 DBMET02813 | DBMET02813 | |
| 0.014 | 0.021 | 0.017 | Telomerase stimulant | 0.016 0.015 DBMET02809 0.017 0.011 DBMET02811 | DBMET02811 | |
| 0.063 | 0.072 | 0.078 | CDC25A inhibitor | 0.078 0.045 DBMET02812 | DBMET02812 | |
| 0.028 | 0.039 | 0.032 | HMG CoA reductase inhibitor | 0.032 0.029 DBMET02811 0.032 0.029 DBMET02812 | DBMET02812 | |
| 0.032 | 0.044 | 0.049 | GABA uptake inhibitor | 0.049 0.016 DBMET02809 | DBMET02809 | |
| 0.018 | 0.031 | 0.022 | Vitamin D receptor antagonist | 0.022 0.015 DBMET02811 | DBMET02811 | |
| 0.039 | 0.059 | 0.065 | Beta tubulin antagonist | 0.065 0.037 DBMET02809 0.055 0.043 DBMET02812 0.053 0.044 DBMET02813 | DBMET02809 | |
| 0.042 | 0.063 | 0.075 | HIV-1 integrase (Strand Transfer) inhibitor | 0.075 0.033 DBMET02811 | DBMET02811 | |
| 0.092 | 0.117 | 0.107 | Bone formation stimulant | 0.107 0.098 DBMET02812 | DBMET02812 | |
| 0.021 | 0.06 | 0.03 | Hedgehog signaling activator | 0.03 0.013 DBMET02809 | DBMET02809 | |
| 0.076 | 0.116 | 0.097 | GABA receptor agonist | 0.097 0.081 DBMET02809 | DBMET02809 | |
| 0.071 | 0.113 | 0.098 | T cell inhibitor | 0.098 0.027 DBMET02811 0.097 0.027 DBMET02812 0.082 0.058 DBMET02813 | DBMET02811 | |
| 0.033 | 0.076 | 0.053 | Alpha tubulin antagonist | 0.048 0.044 DBMET02809 0.053 0.037 DBMET02812 | DBMET02812 | |
| 0.128 | 0.189 | 0.326 | Tumour necrosis factor alpha release inhibitor | 0.326 0.044 DBMET02811 0.155 0.152 DBMET02812 | DBMET02811 | |
| 0.094 | 0.155 | 0.177 | Neurotrophic factor | 0.177 0.039 DBMET02812 | DBMET02812 | |
| 0.079 | 0.146 | 0.135 | Cytokine production inhibitor | 0.135 0.075 DBMET02813 | DBMET02813 | |
| 0.119 | 0.187 | 0.15 | Phospholipase C inhibitor | 0.15 0.105 DBMET02812 | DBMET02812 | |
| 0.067 | 0.136 | 0.145 | Adenylate cyclase inhibitor | 0.101 0.083 DBMET02809 0.145 0.049 DBMET02812 | DBMET02812 | |
| 0.028 | 0.106 | 0.048 | GABA A receptor antagonist | 0.048 0.044 DBMET02809 | DBMET02809 | |
| 0.028 | 0.106 | 0.051 | GABA receptor antagonist | 0.051 0.043 DBMET02809 | DBMET02809 | |
| 0.108 | 0.195 | 0.162 | Hypolipemic | 0.159 0.128 DBMET02809 0.162 0.125 DBMET02811 0.151 0.135 DBMET02812 | DBMET02811 | |
| 0.071 | 0.195 | 0.131 | Interleukin 4 antagonist | 0.131 0.07 DBMET02811 0.126 0.077 DBMET02812 0.124 0.08 DBMET02813 | DBMET02811 | |
| 0.086 | 0.213 | 0.177 | Growth hormone agonist | 0.177 0.069 DBMET02812 | DBMET02812 | |
| 0.137 | 0.268 | 0.206 | Transcription factor STAT inhibitor | 0.206 0.13 DBMET02813 | DBMET02813 | |
| 0.174 | 0.316 | 0.255 | Cyclophilin D inhibitor | 0.255 0.208 DBMET02809 0.243 0.221 DBMET02812 | DBMET02809 | |
| 0.052 | 0.203 | 0.121 | Interleukin 5 antagonist | 0.08 0.073 DBMET02812 0.121 0.023 DBMET02813 | DBMET02813 | |
| 0.049 | 0.22 | 0.103 | Amylase inhibitor | 0.103 0.094 DBMET02812 | DBMET02812 | |
| 0.047 | 0.227 | 0.101 | Beta glucuronidase inhibitor | 0.101 0.068 DBMET02813 | DBMET02813 | |
| 0.071 | 0.263 | 0.168 | Antimitotic | 0.168 0.105 DBMET02812 | DBMET02812 | |
| 0.115 | 0.312 | 0.216 | Vasodilator, peripheral | 0.216 0.158 DBMET02812 | DBMET02812 | |
| 0.083 | 0.286 | 0.205 | Vasodilator | 0.205 0.101 DBMET02812 | DBMET02812 | |
| 0.1 | 0.322 | 0.211 | Transcription factor STAT3 inhibitor | 0.211 0.12 DBMET02813 | DBMET02813 | |
| 0.042 | 0.267 | 0.086 | Thioredoxin inhibitor | 0.086 0.069 DBMET02811 | DBMET02811 | |
| 0.005 | 0.552 | 0.07 | Prostaglandin EP2 antagonist | 0.07 0.033 DBMET02812 | DBMET02812 | |
| 0.023 | 0.956 | 0.232 | MAP kinase kinase 6 inhibitor | 0.232 0.215 DBMET02811 | DBMET02811 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |